These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 22859522)

  • 1. Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humans.
    Yu G; Kovkarova-Naumovski E; Jara P; Parwani A; Kass D; Ruiz V; Lopez-Otín C; Rosas IO; Gibson KF; Cabrera S; Ramírez R; Yousem SA; Richards TJ; Chensny LJ; Selman M; Kaminski N; Pardo A
    Am J Respir Crit Care Med; 2012 Oct; 186(8):752-62. PubMed ID: 22859522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial cell-derived MMP19 promotes pulmonary fibrosis by inducing E(nd)MT and monocyte infiltration.
    Zhao W; Wang L; Yang J; Chen X; Guo X; Xu K; Wang N; Zhao W; Xia C; Lian H; Rosas I; Yu G
    Cell Commun Signal; 2023 Mar; 21(1):56. PubMed ID: 36915092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of MT1-MMP in Alveolar Epithelial Cells Exacerbates Pulmonary Fibrosis.
    Placido L; Romero Y; Maldonado M; Toscano-Marquez F; Ramírez R; Calyeca J; Mora AL; Selman M; Pardo A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation and Nuclear Location of MMP28 in Alveolar Epithelium of Idiopathic Pulmonary Fibrosis.
    Maldonado M; Salgado-Aguayo A; Herrera I; Cabrera S; Ortíz-Quintero B; Staab-Weijnitz CA; Eickelberg O; Ramírez R; Manicone AM; Selman M; Pardo A
    Am J Respir Cell Mol Biol; 2018 Jul; 59(1):77-86. PubMed ID: 29373068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
    Craig VJ; Zhang L; Hagood JS; Owen CA
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.
    Valero-Jiménez A; Zúñiga J; Cisneros J; Becerril C; Salgado A; Checa M; Buendía-Roldán I; Mendoza-Milla C; Gaxiola M; Pardo A; Selman M
    PLoS One; 2018; 13(3):e0192963. PubMed ID: 29529050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury.
    Craig VJ; Quintero PA; Fyfe SE; Patel AS; Knolle MD; Kobzik L; Owen CA
    J Immunol; 2013 Apr; 190(8):4283-96. PubMed ID: 23487425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase (MMP)-19-deficient fibroblasts display a profibrotic phenotype.
    Jara P; Calyeca J; Romero Y; Plácido L; Yu G; Kaminski N; Maldonado V; Cisneros J; Selman M; Pardo A
    Am J Physiol Lung Cell Mol Physiol; 2015 Mar; 308(6):L511-22. PubMed ID: 25575513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis.
    Nkyimbeng T; Ruppert C; Shiomi T; Dahal B; Lang G; Seeger W; Okada Y; D'Armiento J; Günther A
    PLoS One; 2013; 8(9):e73279. PubMed ID: 24023851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition.
    Hatipoglu OF; Uctepe E; Opoku G; Wake H; Ikemura K; Ohtsuki T; Inagaki J; Gunduz M; Gunduz E; Watanabe S; Nishinaka T; Takahashi H; Hirohata S
    Biomed Pharmacother; 2021 Jul; 139():111633. PubMed ID: 34243624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix Metalloproteinases Retain Soluble FasL-mediated Resistance to Cell Death in Fibrotic-Lung Myofibroblasts.
    Nareznoi D; Konikov-Rozenman J; Petukhov D; Breuer R; Wallach-Dayan SB
    Cells; 2020 Feb; 9(2):. PubMed ID: 32053892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis.
    Yamashita CM; Dolgonos L; Zemans RL; Young SK; Robertson J; Briones N; Suzuki T; Campbell MN; Gauldie J; Radisky DC; Riches DW; Yu G; Kaminski N; McCulloch CA; Downey GP
    Am J Pathol; 2011 Oct; 179(4):1733-45. PubMed ID: 21871427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis.
    Pardo A; Gibson K; Cisneros J; Richards TJ; Yang Y; Becerril C; Yousem S; Herrera I; Ruiz V; Selman M; Kaminski N
    PLoS Med; 2005 Sep; 2(9):e251. PubMed ID: 16128620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and activation of matrix metalloproteinase 7 (matrilysin 1) in the lungs of patients with idiopathic pulmonary fibrosis.
    Fujishima S; Shiomi T; Yamashita S; Yogo Y; Nakano Y; Inoue T; Nakamura M; Tasaka S; Hasegawa N; Aikawa N; Ishizaka A; Okada Y
    Arch Pathol Lab Med; 2010 Aug; 134(8):1136-42. PubMed ID: 20670133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mononuclear phagocytes and airway epithelial cells: novel sources of matrix metalloproteinase-8 (MMP-8) in patients with idiopathic pulmonary fibrosis.
    Craig VJ; Polverino F; Laucho-Contreras ME; Shi Y; Liu Y; Osorio JC; Tesfaigzi Y; Pinto-Plata V; Gochuico BR; Rosas IO; Owen CA
    PLoS One; 2014; 9(5):e97485. PubMed ID: 24828408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase (MMP)-1 induces lung alveolar epithelial cell migration and proliferation, protects from apoptosis, and represses mitochondrial oxygen consumption.
    Herrera I; Cisneros J; Maldonado M; Ramírez R; Ortiz-Quintero B; Anso E; Chandel NS; Selman M; Pardo A
    J Biol Chem; 2013 Sep; 288(36):25964-25975. PubMed ID: 23902766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced deoxycytidine kinase contributes to epithelial proliferation in pulmonary fibrosis.
    Weng T; Poth JM; Karmouty-Quintana H; Garcia-Morales LJ; Melicoff E; Luo F; Chen NY; Evans CM; Bunge RR; Bruckner BA; Loebe M; Volcik KA; Eltzschig HK; Blackburn MR
    Am J Respir Crit Care Med; 2014 Dec; 190(12):1402-12. PubMed ID: 25358054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis.
    Pullamsetti SS; Savai R; Dumitrascu R; Dahal BK; Wilhelm J; Konigshoff M; Zakrzewicz D; Ghofrani HA; Weissmann N; Eickelberg O; Guenther A; Leiper J; Seeger W; Grimminger F; Schermuly RT
    Sci Transl Med; 2011 Jun; 3(87):87ra53. PubMed ID: 21677199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alveolar epithelial TET2 is not involved in the development of bleomycin-induced pulmonary fibrosis.
    Qin W; Crestani B; Spek CA; Scicluna BP; van der Poll T; Duitman J
    FASEB J; 2021 May; 35(5):e21599. PubMed ID: 33913570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.